Xeri Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xeri board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xeri Board Today - Breaking & Trending Today

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Compensation Committee Of Xeri Board Directors , Xeris Biopharma Holdings , Xeris Biopharma Holdings Inc , Xeris Pharmaceuticals Announces Inducement Grants Under , Biopharma Holdings , Compensation Committee , Xeri Board , Xeri Inducement Equity , Inducement Equity Plan , Xeri Inducement Equity Plan ,

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on January 2, 2024, the. ....

United States , Xeris Biopharma Holdings , Xeris Biopharma Holdings Inc , Xeris Pharmaceuticals Announces Inducement Grants Under , Compensation Committee Of Xeri Board Directors , Biopharma Holdings , Compensation Committee , Xeri Board , Xeri Inducement Equity , Inducement Equity Plan , Xeri Inducement Equity Plan ,

Xeris Pharmaceuticals Announced Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)


Published: Dec 31, 2020
 
 
CHICAGO (BUSINESS WIRE) Xeris Pharmaceuticals, Inc., Inc. (NASDAQ: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on December 30, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 38,250 shares, and restricted stock units for an aggregate of 35,100 shares, of its common stock to 7 new employee(s) under Xeris’ Inducement Equity Plan.
Xeris’ Inducement Equity Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Xeris or one of its subsidiaries as an inducement material to such individual s entering into employment with Xeris or one of its subsidiaries, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The non-qualified stock options will vest over a period o ....

United States , Xeris Pharmaceuticals Inc , Compensation Committee Of Xeri Board Directors , Compensation Committee , Xeri Board , Xeri Inducement Equity , Inducement Equity Plan , Xeri Inducement Equity Plan , Xeris Pharmaceuticals , Xeris Pharmaceuticals Announced Inducement Grants Under Nasdaq Listing Rule 5635c 4 , ஒன்றுபட்டது மாநிலங்களில் , இழப்பீடு குழு ,